BDBM463312 (-)-(2R)-1-(benzimidazol-4- ylmethyl)-N-(9-chloro-3,4- dihydro-2H-1,5- benzodioxepin-7-ylmethyl)-N- isobutylpiperidine-2- carboxamide::US10780095, Structure TABLE 1.10

SMILES CC(C)CN(Cc1cc(Cl)c2OCCCOc2c1)C(=O)C1CN(Cc2cccc3nc[nH]c23)CCO1

InChI Key InChIKey=QGZNVUJOSDSAHH-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 463312   

TargetProkineticin receptor 2(Human)
University of California

US Patent
LigandPNGBDBM463312((-)-(2R)-1-(benzimidazol-4- ylmethyl)-N-(9-chloro-...)
Affinity DataKi:  1.30nMAssay Description:An aequorin-based luminescent assay for calcium mobilization was used to measure mobilization of intracellular Ca2+ (Bullock et al., Mol Pharmacol 65...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2021
Entry Details
Go to US Patent

TargetProkineticin receptor 1(Human)
University of California

US Patent
LigandPNGBDBM463312((-)-(2R)-1-(benzimidazol-4- ylmethyl)-N-(9-chloro-...)
Affinity DataKi:  8.40nMAssay Description:An aequorin-based luminescent assay for calcium mobilization was used to measure mobilization of intracellular Ca2+ (Bullock et al., Mol Pharmacol 65...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2021
Entry Details
Go to US Patent